WaveMan
WaveMan · Company
IBEX · Ibex Ltd
> Search tickers & screens ⌘K
LIVE
← All companies

IBEX Ibex (IBEX) Insider Trading, Ownership & Congress Trades

Software & IT · Services-computer processing & data preparation · CIK 0001720420
Quote by TradingView
Form 144 · 11
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
82
13F, latest reported quarter

What the filings say about IBEX

Insiders, 180 days
-$4.9M net sold
10 sellers · 24% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$3.9M
11 notices

Ibex insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, IBEX Ltd insiders sold a net $4.9M of stock across 194 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-29.

Insider
Filed
Shares
Value
Since filing
Dechant Robert Thomas
Chief Executive Officer
SELL
2026-09-29 SECtraded 2026-09-25
5,000
$225.1K
+6.2%
Context
  • 21 earlier Form 4 trades (code P or S) here by this insider (21 sales), the last on Sep 15, 2026.
  • The trade is 1.9% of the 257,011 shares held after it.
  • 6 other insiders sold within 30 days.
  • 82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Dechant Robert Thomas sold about $225.1K of IBEX under a 10b5-1 plan on Sep 25, 2026; 6 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
Inson Paul Joseph
Chief People Officer
SELL
2026-09-16 SEC
2,500
$100.2K
+12.3%
Context
  • 12 earlier Form 4 trades (code P or S) here by this insider (12 sales), the last on Sep 14, 2026.
  • The trade is 9.2% of the 27,224 shares held after it.
  • 6 other insiders sold within 30 days.
  • 82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief People Officer Inson Paul Joseph sold about $100.2K of IBEX on Sep 16, 2026; 6 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
Trofimuk-O'Connor Christina Alice
Chief Legal Officer
SELL
2026-09-16 SEC
2,376
$93.5K
+12.3%
Context
  • 10 earlier Form 4 trades (code P or S) here by this insider (10 sales), the last on Sep 15, 2026.
  • The trade is 8.8% of the 26,855 shares held after it.
  • 6 other insiders sold within 30 days.
  • 82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer Trofimuk-O'Connor Christina Alice sold about $93.5K of IBEX on Sep 16, 2026; 6 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
Zhuang Mingzhe
Director
SELL
2026-09-16 SECtraded 2026-09-15
5,522
$221.4K
+12.3%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 196.3% of the 2,813 shares held after it.
  • 6 other insiders sold within 30 days.
  • 82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Zhuang Mingzhe sold about $221.4K of IBEX on Sep 15, 2026; 6 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
Dechant Robert Thomas
Chief Executive Officer
SELL
2026-09-16 SECtraded 2026-09-15
25,000
$999.7K
+12.3%
Context
  • 20 earlier Form 4 trades (code P or S) here by this insider (20 sales), the last on May 13, 2026.
  • The trade is 9.5% of the 262,011 shares held after it.
  • 6 other insiders sold within 30 days.
  • 82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Dechant Robert Thomas sold about $999.7K of IBEX on Sep 15, 2026; 6 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
194 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 189 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$4.9M over 180 days
-$3.9M over 90 days
below 60% of Software & IT
Congress
no House purchase disclosed in the last 12 months
Funds
82 funds bought in last quarter
below 53% of Software & IT
Revenue
+15.4% year over year
more than 63% of Software & IT
Margin
7.2% net margin
more than 68% of Software & IT
Buybacks
$14.4M repurchased, FY to 2026-06-30
below 72% of Software & IT
Short interest
1.6% of the float short (float per yahoo 2026-10-27) · 2.3 days to cover · settled 2026-10-15
below 61% of Software & IT
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch IBEX

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+20.3%12M
-31%-13%+5%+24%2025-102025-122026-022026-042026-062026-082026-10 2026-09-15 · Dechant Robert Thomas sold $999.7K2026-09-15 · Casteel Julie K sold $706.1K2026-09-08 · Afdahl David Martin sold $649.0K2026-05-12 · Dawson Bruce Neil sold $474.9K2026-09-14 · Afdahl David Martin sold $433.5K2026-09-15 · Trofimuk-O'Connor Christina Alice sold $302.3K2026-05-13 · Dechant Robert Thomas sold $237.9K2026-09-25 · Dechant Robert Thomas sold $225.1K2026-09-15 · Zhuang Mingzhe sold $221.4K2026-02-18 · Dechant Robert Thomas sold $179.9K2026-02-19 · Dechant Robert Thomas sold $178.4K2026-02-17 · Dechant Robert Thomas sold $177.8K2026-02-20 · Dechant Robert Thomas sold $176.4K2026-02-23 · Dechant Robert Thomas sold $170.8K2026-06-11 · Casteel Julie K sold $110.2K2026-05-11 · Dawson Bruce Neil sold $102.6K2026-09-16 · Inson Paul Joseph sold $100.2K2026-09-16 · Trofimuk-O'Connor Christina Alice sold $93.5K2026-02-06 · Inson Paul Joseph sold $91.9K2026-09-14 · Inson Paul Joseph sold $91.0K2026-09-15 · Ballou-Aares Daniella sold $60.4K2026-02-06 · Darwal Michael Joseph sold $58.1K2026-05-28 · McGinnis Patrick sold $32.6K2026-05-22 · Greenwald Taylor C sold $30.9K2025-12-02 · Ballou-Aares Daniella sold $17.5K2026-09-25 · Dechant Robert Thomas filed to sell $225.1K2026-09-18 · Ballou-Aares Daniella filed to sell $60.4K2026-09-16 · Christina Alice Trofimuk OConnor filed to sell $93.5K2026-09-16 · Paul Inson filed to sell $100.2K2026-09-15 · Julie Casteel filed to sell $706.1K2026-09-15 · Robert Dechant filed to sell $999.7K2026-09-15 · Christina Alice Trofimuk OConnor filed to sell $302.3K2026-09-15 · Mingzhe Zhuang filed to sell $221.4K2026-09-14 · Afdahl David Martin filed to sell $433.5K2026-09-14 · Inson Paul Joseph filed to sell $91.0K2026-09-08 · Afdahl David Martin filed to sell $649.0K
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns IBEX: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
1,035,490 sh
$31.4M
AMERICAN CENTURY COMPANIES INC
510,633 sh
$15.5M
DIMENSIONAL FUND ADVISORS LP
385,153 sh
$11.7M
TWO SIGMA INVESTMENTS, LP
380,613 sh
$11.6M
AMERIPRISE FINANCIAL INC
374,741 sh
$11.4M

Congress trades in IBEX

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

IBEX planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Dechant Robert Thomas
Filed 2026-09-25
$225.1K
Ballou-Aares Daniella
Filed 2026-09-18
$60.4K
Christina Alice Trofimuk OConnor
Filed 2026-09-16
$93.5K
Paul Inson
Filed 2026-09-16
$100.2K
Julie Casteel
Filed 2026-09-15
$706.1K

IBEX mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Victory Integrity Discovery Fund
$546.7K position · as of 2026-06-30
0.6%
iShares US Small Cap Value Factor ETF
$833.6K position · as of 2026-06-30
0.4%
ACUITAS US MICROCAP FUND
$408.0K position · as of 2026-06-30
0.3%
North Star Micro Cap Fund
$632.8K position · as of 2026-05-31
0.3%
Sterling Capital Behavioral Small Cap Value Fund
$223.1K position · as of 2026-06-30
0.3%
Barrons 400 ETF
$546.6K position · as of 2026-05-31
0.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $4.9M sold by insiders over 180 days, 82 funds added last quarter, $3.9M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
TEAMMETACRWVCRMCRWDNETDDOGAPPIOTPCTYDUOLMDB

IBEX financials

Revenue growth
+15.4%
XBRL, annual
Net margin
7.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$644.1M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+0.0%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$31.2M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.01x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Cash flow to debt
35.56x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Return on equity
+0.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+0.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
+36.1%
operating income after a 14.7% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on capital employed
+26.4%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
14.68x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
$579.1M
market value at close 2026-10-27 on 2026-08-31 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
FCF yield
+5.1%
TTM free cash flow over market value at close 2026-10-27
PEG, trailing
0.47x
P/E over trailing EPS growth of 31%: four quarters to 2026-06-30 against the four to 2025-06-30
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2026-062025-062024-062023-06
Revenue$644.1M$558.3M$508.6M$523.1M
Operating income$55.0M$46.6M$39.4M$40.5M
Net income$46$37$34$31.6M
EPS (diluted)n/an/an/a1.67
Operating cash flow$59.0M$45.7M$35.9M$41.9M
Cash$32.6M$15.3M$62.7M$57.4M
Long-term debt$777.0K$796.0K$867.0K$600.0K
Buybacks$14.4M$78.0M$21.6M$276.0K
Dividends paidn/an/an/a$0
SEC XBRL, fiscal years, as known on 2026-10-29

IBEX Stock Sonar score 6/7 axes

Find similar shapesCompare

IBEX ranks highest on financial health (89th percentile) and profitability (73rd), and lowest on insider conviction (20th), among Software & IT peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
73
Inputs
  • Return on equity+0.0% · 49 pct, sector of 286
  • Return on assets+0.0% · 57 pct, sector of 381
  • Return on invested capital+36.1% · 91 pct, sector of 78
  • Return on capital employed+26.4% · 94 pct, sector of 294
Financial health
89
Inputs
  • Debt to equity0.01x · 79 pct, sector of 288
  • Cash flow to debt35.56x · 98 pct, sector of 241
Growth
63
Inputs
  • Revenue growth, YoY+15.4% · 63 pct, sector of 480
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
20
Inputs
  • Net Form 4 buying (codes P and S), 180d-$3.5M · 40 pct, sector of 284
  • Insider buyers, 180d0 · 0 pct, sector of 290
Institutional and government
47
Inputs
  • Funds adding, latest quarter82 · 47 pct, sector of 415
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
70
Inputs
  • Short interest, % of float+1.6% · 73 pct, sector of 528
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+8.3% · 67 pct, sector of 316
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

IBEX filings, in plain words

Are Ibex insiders buying or selling IBEX?

In the 180 days to 2026-10-29, Ibex insiders were net sellers, a net $4.9M across purchases and sales reported on Form 4, by 10 sellers.

Are there planned insider sales of IBEX?

Yes. 11 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-29, covering $3.9M of stock; the latest, by Dechant Robert Thomas, was filed 2026-09-25.

Read the full summary

In the 180 days to 2026-10-29, Ibex insiders were net sellers of IBEX, a net $4.9M across purchases and sales reported on Form 4 by 10 sellers. 24% of the 17 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 11 Form 144 notices of intent to sell in the 90 days to 2026-10-29, covering $3.9M of stock. Each figure is counted from SEC and House filings as of 2026-10-29, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies